Cosmos Health Inc.
COSM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $54 | $53 | $50 | $56 |
| % Growth | 2% | 6% | -10.5% | – |
| Cost of Goods Sold | $50 | $49 | $44 | $48 |
| Gross Profit | $4 | $4 | $6 | $8 |
| % Margin | 7.9% | 8.1% | 11.8% | 14.8% |
| R&D Expenses | $1 | $0 | $0 | $0 |
| G&A Expenses | $12 | $24 | $13 | $12 |
| SG&A Expenses | $12 | $26 | $13 | $12 |
| Sales & Mktg Exp. | $0 | $1 | $1 | $1 |
| Other Operating Expenses | $7 | $1 | $0 | $0 |
| Operating Expenses | $20 | $26 | $13 | $13 |
| Operating Income | -$16 | -$22 | -$7 | -$5 |
| % Margin | -28.6% | -40.9% | -14.8% | -8.1% |
| Other Income/Exp. Net | -$1 | $3 | -$6 | -$3 |
| Pre-Tax Income | -$16 | -$19 | -$13 | -$8 |
| Tax Expense | $0 | $0 | $1 | $0 |
| Net Income | -$16 | -$19 | -$14 | -$8 |
| % Margin | -29.7% | -34.7% | -27.5% | -14.2% |
| EPS | -1.17 | -2.15 | -33.16 | -23.74 |
| % Growth | 45.6% | 93.5% | -39.7% | – |
| EPS Diluted | -1.17 | -2.15 | -33.16 | -23.74 |
| Weighted Avg Shares Out | 19 | 12 | 2 | 1 |
| Weighted Avg Shares Out Dil | 19 | 12 | 2 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $0 |
| Interest Expense | $1 | $1 | $4 | $4 |
| Depreciation & Amortization | $1 | $1 | $0 | $0 |
| EBITDA | -$14 | -$17 | -$9 | -$4 |
| % Margin | -25.6% | -32% | -17.7% | -6.8% |